S. Kakolyris

Molecular Detection of Cytokeratin-19–Positive Cells in the Peripheral Blood of Patients With Operable Breast Cancer: Evaluation of Their Prognostic Significance

Aliki Stathopoulou, Ioannis G. Vlachonikolis, D. Mavroudis et al. · Journal of Clinical Oncology · 2002 · 340 citations

Subcutaneous Administration of Amifostine During Fractionated Radiotherapy: A Randomized Phase II Study

Michael I. Koukourakis, George Kyrias, S. Kakolyris et al. · Journal of Clinical Oncology · 2000 · 272 citations

Thioredoxin expression is associated with lymph node status and prognosis in early operable non-small cell lung cancer.

S. Kakolyris, Alexandra Giatromanolaki, Michael I. Koukourakis et al. · PubMed · 2001 · 161 citations

A multicenter randomized clinical trial comparing paclitaxel–cisplatin–etoposide versus cisplatin–etoposide as first-line treatment in patients with small-cell lung cancer

Dimitriοs Mavroudis, E. Papadakis, M. Veslemes et al. · Annals of Oncology · 2001 · 159 citations · Full text

Paclitaxel–cisplatin–etoposide Versus Cisplatin–etoposide, Medicine, Metronomic Therapy +10

Vascular endothelial growth factor, wild-type p53, and angiogenesis in early operable non-small cell lung cancer.

Alexandra Giatromanolaki, Michael I. Koukourakis, S. Kakolyris et al. · PubMed · 1998 · 130 citations

Tumor Biology, Wild-type P53, Angiogenesis +15